Guiyang Xintian Pharmaceutical Co.,Ltd.

SZSE:002873.SZ

11.54 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Revenue 953.9821,087.673969.844750.946773.337694.259681.714633.186521.911454.126406.127330.089
Cost of Revenue 218.758247.287201.157165.328162.58145.713132.608115.29685.72281.7285.76578.556
Gross Profit 735.224840.387768.687585.618610.757548.546549.107517.89436.189372.405320.362251.533
Gross Profit Ratio 0.7710.7730.7930.780.790.790.8050.8180.8360.820.7890.762
Reseach & Development Expenses 38.13521.58520.37713.29521.10131.83323.08313.91613.08311.2381.7821.3
General & Administrative Expenses 50.44945.56753.84844.1354.85658.06839.54934.37333.08832.61636.13820.423
Selling & Marketing Expenses 437.539531.978471.824365.868381.859347.36385.928365.41305.613258.864237.687179.964
SG&A 487.988577.545525.671409.998436.714405.428425.477399.782338.701291.48273.826200.387
Other Expenses -1.326102.43285.53469.67162.56539.253-0.09814.2184.9642.6813.3424.889
Operating Expenses 631.431701.562631.582492.964520.38476.514478.015442.485376.678323.994292.851216.798
Operating Income 93.743122.167117.11486.35683.43574.58574.71161.61843.08334.41113.54625.509
Operating Income Ratio 0.0980.1120.1210.1150.1080.1070.110.0970.0830.0760.0330.077
Total Other Income Expenses Net -1.326-0.572-0.465-2.414-0.3916.78-0.0982.4984.6142.6812.9584.859
Income Before Tax 92.417121.595116.64883.94283.04481.36574.61364.11547.69737.09216.50430.369
Income Before Tax Ratio 0.0970.1120.120.1120.1070.1170.1090.1010.0910.0820.0410.092
Income Tax Expense 11.5465.49316.0439.83912.17810.978.4967.0465.6873.9681.4093.976
Net Income 80.871111.51999.47672.54671.42270.97566.11757.06942.0133.12415.09526.393
Net Income Ratio 0.0850.1030.1030.0970.0920.1020.0970.090.080.0730.0370.08
EPS 0.350.510.450.330.320.310.320.330.240.190.0870.15
EPS Diluted 0.330.480.410.310.320.310.320.330.240.190.0870.15
EBITDA 124.902162.812159.153109.158108.608101.03684.96989.27770.59155.59430.67739.571
EBITDA Ratio 0.1310.150.1640.1450.140.1460.1250.1410.1350.1220.0760.12